# Comparison of Immunogenicity of Inactivated Poliovirus Vaccine (IPV) Administered Intramuscularly or Intradermally

> **NCT04027036** · PHASE2 · COMPLETED · sponsor: **Instituto Nacional de Saúde, Mozambique** · enrollment: 382 (actual)

## Conditions studied

- Polio

## Interventions

- **BIOLOGICAL:** Inactivated poliovirus vaccine in reduced doses

## Key facts

- **NCT ID:** NCT04027036
- **Lead sponsor:** Instituto Nacional de Saúde, Mozambique
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-06
- **Primary completion:** 2022-05-31
- **Final completion:** 2022-05-31
- **Target enrollment:** 382 (ACTUAL)
- **Last updated:** 2024-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04027036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04027036, "Comparison of Immunogenicity of Inactivated Poliovirus Vaccine (IPV) Administered Intramuscularly or Intradermally". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04027036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*